BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2858492)

  • 1. Blocking type antithyrotropin receptor antibody in patients with nongoitrous hypothyroidism: its incidence and characteristics of action.
    Arikawa K; Ichikawa Y; Yoshida T; Shinozawa T; Homma M; Momotani N; Ito K
    J Clin Endocrinol Metab; 1985 May; 60(5):953-9. PubMed ID: 2858492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential serum measurements of thyrotropin binding inhibitor immunoglobulin G in transient familial neonatal hypothyroidism.
    Iseki M; Shimizu M; Oikawa T; Hojo H; Arikawa K; Ichikawa Y; Momotani N; Ito K
    J Clin Endocrinol Metab; 1983 Aug; 57(2):384-7. PubMed ID: 6134748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for thyrotropin (TSH)-blocking activity in goitrous Hashimoto's thyroiditis with assays measuring inhibition of TSH receptor binding and TSH-stimulated thyroid adenosine 3',5'-monophosphate responses/cell growth by immunoglobulins.
    Takasu N; Yamada T; Katakura M; Yamauchi K; Shimizu Y; Ishizuki Y
    J Clin Endocrinol Metab; 1987 Feb; 64(2):239-45. PubMed ID: 2878935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
    Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A
    Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves' disease and Hashimoto's thyroiditis.
    Endo K; Kasagi K; Konishi J; Ikekubo K; Okuno T; Takeda Y; Mori T; Torizuka K
    J Clin Endocrinol Metab; 1978 May; 46(5):734-9. PubMed ID: 45421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioreceptor assay of anti-TSH receptor antibody activity: comparison of assays using unextracted serum and immunoglobulin fractions, and standardization of expression of activities.
    Tamaki H; Amino N; Watanabe Y; Aozasa M; Hayashi H; Tachi J; Miyai K
    J Clin Lab Immunol; 1986 May; 20(1):1-6. PubMed ID: 3016274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Goitrous hypothyroidism with blocking or stimulating thyrotropin binding inhibitor immunoglobulins.
    Sato K; Okamura K; Yoshinari M; Ikenoue H; Kuroda T; Torisu M; Fujishima M
    J Clin Endocrinol Metab; 1990 Oct; 71(4):855-60. PubMed ID: 1976127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanism of spontaneous hypothyroidism in patients with Graves' disease after antithyroid drug treatment.
    Tamai H; Hirota Y; Kasagi K; Matsubayashi S; Kuma K; Iida Y; Konishi J; Okimura MC; Walter RM; Kumagai LF
    J Clin Endocrinol Metab; 1987 Apr; 64(4):718-22. PubMed ID: 2434520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of blocking TSH receptor antibodies on the development of hypothyroidism and thyroid atrophy in primary myxedema.
    Cho BY; Shong YK; Lee HK; Koh CS; Min HK; Sohn I
    Korean J Intern Med; 1989 Jul; 4(2):108-17. PubMed ID: 2577255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of thyrotropin-stimulated iodide uptake in FRTL-5 thyroid cells by crude immunoglobulin fractions from patients with goitrous and atrophic autoimmune thyroiditis.
    Tokuda Y; Kasagi K; Iida Y; Hatabu H; Misaki T; Arai K; Endo K; Konishi J
    J Clin Endocrinol Metab; 1988 Aug; 67(2):251-8. PubMed ID: 2899088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulating and blocking thyroid-stimulating hormone (TSH) receptor autoantibodies from patients with Graves' disease and autoimmune hypothyroidism have very similar concentration, TSH receptor affinity, and binding sites.
    Morgenthaler NG; Ho SC; Minich WB
    J Clin Endocrinol Metab; 2007 Mar; 92(3):1058-65. PubMed ID: 17179194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of anti-TSH antibody in sera from patients with Graves' disease and other thyroid disorders.
    Akamizu T; Mori T; Imura H; Noh J; Hamada N; Ito K; Koizumi Y; Yamada T; Fujihira T; Eto S
    J Endocrinol Invest; 1989; 12(7):483-8. PubMed ID: 2571629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of thyrotropin-induced adenosine 3'5'-monophosphate increase by immunoglobulins from patients with primary myxedema.
    Konishi J; Iida Y; Endo K; Misaki T; Nohara Y; Matsuura N; Mori T; Torizuka K
    J Clin Endocrinol Metab; 1983 Sep; 57(3):544-9. PubMed ID: 6135705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyrotropin binding inhibiting immunoglobulins (TBII) in Graves' disease, toxic nodular goitre and autoimmune thyroiditis.
    Wägar G; Mäkinen T; Lamberg BA; Gordin A; Apter L; Pekonen F
    Ann Clin Res; 1982 Apr; 14(2):83-9. PubMed ID: 6184007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of thyrotropin-stimulated adenylate cyclase activation and growth of rat thyroid cells, FRTL-5, by immunoglobulin G from patients with primary myxedema: comparison with activities of thyrotropin-binding inhibitor immunoglobulins.
    Cho BY; Shong YK; Lee HK; Koh CS; Min HK
    Acta Endocrinol (Copenh); 1989 Jan; 120(1):99-106. PubMed ID: 2563181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective method for prediction of transient hypothyroidism in neonates born to mothers with chronic thyroiditis.
    Tamaki H; Amino N; Aozasa M; Mori M; Iwatani Y; Tachi J; Nose O; Tanizawa O; Miyai K
    Am J Perinatol; 1989 Jul; 6(3):296-303. PubMed ID: 2567172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the levels of TSH-binding inhibitor immunoglobulins in goitrous and agoitrous autoimmune thyroiditis after twelve months of L-thyroxine therapy.
    Khoo DH; Eng PH; Ho SC; Fok AC
    Clin Endocrinol (Oxf); 1999 Jul; 51(1):73-9. PubMed ID: 10468968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera.
    Rotella CM; Zonefrati R; Toccafondi R; Valente WA; Kohn LD
    J Clin Endocrinol Metab; 1986 Feb; 62(2):357-67. PubMed ID: 2416769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative correlation between the conversion of thyrotropin receptor-bound blocking type thyrotropin receptor antibody to the stimulating type by anti-human IgG antibodies and the biological activity of blocking type thyrotropin receptor antibody.
    Cho BY; Shong MH; Chung JH; Lee HK; Koh CS; Min HK
    J Korean Med Sci; 1993 Oct; 8(5):355-60. PubMed ID: 7905742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterization of monoclonal antithyrotropin receptor antibodies obtained from peripheral lymphocytes of hypothyroid patients with primary myxedema.
    Okuda J; Akamizu T; Sugawa H; Matsuda F; Hua L; Mori T
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1600-4. PubMed ID: 7989462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.